Argenx
ARGX
#555
Rank
S$49.36 B
Marketcap
$784.53
Share price
2.91%
Change (1 day)
46.19%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -$5.63

According to Argenx 's latest financial reports the company's current EPS (TTM) is -$5.59. In 2022 the company made an earnings per share (EPS) of -$17.64.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.63-68.09%
2022-$17.64